Pasura Industries Share Price Today

Arunjyoti Bio Ventures reports net loss of ₹453.61 lakh in FY26

Arunjyoti Bio Ventures reported a net loss of ₹453.61 lakh for FY26, widening from ₹27.62 lakh in FY25, with revenue at ₹2,775.44 lakh.

Arunjyoti Bio Ventures returns to profit in Q1FY27

Arunjyoti Bio Ventures Limited reported a net profit of ₹61.24 lakh for Q1FY27, reversing a loss of ₹204.54 lakh in the same period last year. Revenue from operations stood at ₹820 lakh. The board approved a name change to Pasura Industries Limited, appointed new secretarial auditors, and waived the recovery of excess managerial remuneration of ₹25.19 lakh.

Arunjyoti Bio Ventures Reports Q4FY26 Audited Results with Net Loss of ₹453.61 Lakhs

Arunjyoti Bio Ventures Limited approved audited financial results for Q4FY26 and FY26 at its board meeting on 13.05.2026, reporting a net loss of ₹453.61 lakhs for the full year against a loss of ₹27.62 lakhs in FY25. Revenue from operations for FY26 was ₹2,775.44 lakhs, while exceptional items of ₹273.65 lakhs—comprising bad debt and vendor advance write-offs—significantly impacted Q4FY26 results. The statutory auditors issued an unmodified opinion, and the board also approved the write-off of outstanding debtors and creditors amounting to Rs. 2,73,64,542/-.

Arunjyoti Bio Ventures Reschedules Board Meeting to May 12, 2026

Arunjyoti Bio Ventures Limited has postponed its Board Meeting originally set for May 8, 2026, to May 12, 2026. The meeting will be held at the company's registered office in Telangana to review and approve the audited financial results for the fourth quarter and full year ended March 31, 2026. The agenda remains unchanged, and the intimation was signed by Whole-Time Director P.B.N. Murthy.

Arunjyoti Bio Ventures Limited Reports Share Acquisition by Chennupati Sarath Kumar

Arunjyoti Bio Ventures Limited reported a share acquisition by Chennupati Sarath Kumar under SEBI disclosure requirements. The non-promoter acquired 54,25,516 equity shares representing 2.91% of the company's total capital through open market transactions between April 13-16, 2026, changing his shareholding position in the BSE-listed company.

Arunjyoti Bio Ventures Limited Issues Warning Against Unsolicited Messages Circulating About Company Scrip

Arunjyoti Bio Ventures Limited has issued a regulatory disclosure to BSE Limited on April 13, 2026, under SEBI (LODR) Regulations, warning about unsolicited messages circulating regarding the company's scrip. The company has advised investors to exercise caution while trading shares, with the disclosure signed by Whole-Time Director Pabbathi Badari Narayana Murthy (DIN: 01445523).